Top compounds associated with response to NTMT1


Feature Type Standardized
Nominal ANOVA
mRNA apicidin CTRPv2 pan-cancer AAC -0.09 0.004
mRNA masitinib CTRPv2 pan-cancer AAC -0.1 0.005
mRNA PD 153035 CTRPv2 pan-cancer AAC -0.12 0.005
mRNA Nilotinib CCLE pan-cancer AAC -0.14 0.005
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.005
mRNA Topotecan CCLE pan-cancer AAC 0.12 0.005
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.006
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.099 0.006
mRNA niclosamide CTRPv2 pan-cancer AAC 0.1 0.006
mRNA paclitaxel UHNBreast pan-cancer AAC 0.74 0.006
Download CSV